HEART-FID

STUDY IDENTIFIER:

HEART-FID

CONDITION:

Heart failure with iron deficiency anemia

CONTACT INFO:

Sarah Dennis, RN   |   sarah.dennis@allina.com   |   612-863-6257

DESCRIPTION:

This is a randomized, double blind, placebo-controlled study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose) as treatment for heart failure with iron deficiency. Study drug administration will occur as two intravenous doses every six months for duration of study.

CRITERIA LIST/ QUALIFICATIONS:

 
Inclusion:
  • Stable heart failure with ejection fraction ≤35%
  • Able and willing to perform a walk test
  • Low hemoglobin
  • Willing and able to come to the study site for infusions every 6 months for about 4 years
 
Exclusion:
  • Current or planned LVAD or heart transplantation
  • Recent heart attack or stroke

INVESTIGATORS:

Peter Eckman, MD

SPONSORS:

Luitpold Pharmaceuticals, Inc.

STATUS:

Open/Enrolling

Support the research and educational efforts of MHIF

Make a Donation